(Circulation. 2001;103:2873.)
© 2001 American Heart Association, Inc.
Editorial |
From the Cardiovascular Diseases Section, Department of Medicine, University of Minnesota, Minneapolis, Minn.
Correspondence to Robert F. Wilson, MD, MMC 508, 420 Delaware St SE, Minneapolis, MN 55455. E-mail wilso008@tc.umn.edu
Key Words: Editorials stenosis coronary disease physiology
The selection of patients for coronary revascularization procedures is one of the most important and widely studied decisions in cardiovascular medicine. The article by Bech et al1 in the current issue of Circulation is a landmark study that should guide clinicians in more precisely selecting which stenotic lesions should be dilated and which are better left alone.
Coronary angiography, once a complicated procedure, was developed to determine whether coronary arteries were narrowed enough to restrict blood flow to the myocardium. Now, coronary angiography is easy, but interpretation of the findings has become increasingly difficult as our knowledge of atherosclerosis has broadened. The problems have centered around 2 questions: how much stenosis is needed to cause a clinically significant reduction in blood flow, and does the severity of stenosis relate to its propensity to cause infarction?
The translation of angiographically determined
arterial stenosis to
physiologically relevant reductions in
coronary blood flow dates to the seminal work of Gould et al in
1974.2 He demonstrated in
animals that resting coronary blood flow remained normal until
85% to 90% of the coronary cross-sectional area was occluded.
This is because blood flow in healthy coronary arteries is
regulated by the microcirculation, which has substantial constrictive
tone at rest. With progressive stenosis in the upstream
coronary, the microcirculation dilates. This fall in
microvascular resistance compensates for the stenotic
resistance in the large coronary, preserving overall
coronary resistance and blood flow at rest. This is one of the
reasons that many patients with stenotic lesions have
This article has been cited by other articles:
![]() |
M. Lindstaedt, M. K. Fritz, A. Yazar, C. Perrey, A. Germing, P. H. Grewe, A. M. Laczkovics, A. Mugge, and W. Bojara Optimizing revascularization strategies in patients with multivessel coronary disease: Impact of intracoronary pressure measurements J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 897 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. J. Pijls Is it time to measure fractional flow reserve in all patients? J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1122 - 1124. [Full Text] [PDF] |
||||
![]() |
B. De Bruyne, N. H.J. Pijls, L. Smith, M. Wievegg, and G. R. Heyndrickx Coronary Thermodilution to Assess Flow Reserve: Experimental Validation Circulation, October 23, 2001; 104(17): 2003 - 2006. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |